Loading resource…

Department of Internal Medicine, Specialities Hospital, National Medical Center 'La Raza', Instituto Mexicano del Seguro Social, Mexico City, Mexico
Hyperglycemia in hospitalized patients is a significant healthcare issue that can lead to various complications. The document reviews clinical guidelines recommending subcutaneous insulin as the preferred therapy, while also examining the emerging evidence for incretin-based therapies, particularly GLP-1 receptor agonists and DPP-4 inhibitors. It discusses the efficacy and safety of these treatments in the inpatient setting, emphasizing the need for further research to clarify their roles. An algorithm for managing hyperglycemia in hospitalized patients is proposed based on the available evidence.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology

2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology

METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology

SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology

GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology

DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology

ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology

DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology

OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology